Inflammasome Therapeutics Inc
Dr. Guo has focused on sustained drug delivery technologies and products which can improve the quality of life for patients throughout her career. She has made significant contributions to the design and development of three FDA approved, sustained release, intravitreal implantable/injectable products. Dr. Guo brings over 25 years experience to the team, developing drug products from early feasibility to clinical development and commercialization. She has expertise in various CMC functions including formulation development, analytical development, ocular delivery, preclinical research and regulatory submission. A medicinal chemist by training, Dr. Guo is the inventor/co-inventor for numerous U.S and international patents and applications.
This person is not in any offices
Inflammasome Therapeutics Inc
Inflammasome Therapeutics Inc found to develop therapies for prevalent, degenerative diseases.